Report cover image

C-Reactive Protein Testing Market by Assay Type (Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay), Disease Area (Cancer, Cardiovascular Diseases, Endometriosis), Detection Range, End-User - Global Forecast 2023-2030

Publisher 360iResearch
Published Oct 05, 2023
Length 188 Pages
SKU # IRE18313577

Description

C-Reactive Protein Testing Market by Assay Type (Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay), Disease Area (Cancer, Cardiovascular Diseases, Endometriosis), Detection Range, End-User - Global Forecast 2023-2030


The C-Reactive Protein Testing Market is projected to reach USD 3.42 billion by 2030 from USD 1.34 billion in 2022, at a CAGR of 12.39% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the C-Reactive Protein Testing Market.
  • Based on Assay Type, market is studied across Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay, and Radioimmunoassay. The Chemiluminescence Immunoassay is further studied across Free T3, Free T4, and Thyrotropin Levels. The ELISA is further studied across Clinical and Nonclinical. The Radioimmunoassay is further studied across Autoantibodies Against Thyrotropin Receptor, Human Serum Thyroglobulin Autoantibodies, and Thyroperoxidase Autoantibodies. The Radioimmunoassay is projected to witness significant market share during forecast period.
  • Based on Disease Area, market is studied across Cancer, Cardiovascular Diseases, Endometriosis, Inflammatory Bowel Disease, Lupus, and Rheumatoid Arthritis. The Cardiovascular Diseases is projected to witness significant market share during forecast period.
  • Based on Detection Range, market is studied across cCRP, Conventional CRP, and hs-CRP. The cCRP is projected to witness significant market share during forecast period.
  • Based on End-User, market is studied across Assisted Living Healthcare Facilities, Clinics, Hospitals, and Laboratories. The Assisted Living Healthcare Facilities is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the C-Reactive Protein Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape C-Reactive Protein Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the C-Reactive Protein Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Alere Inc., BIOMÉRIEUX, BODITECH MED, Inc., CTK Biotech Inc., Danaher Corporation, DiaSorin S.p.A., Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Getein Biotech, Inc., HORIBA, Ltd., Laboratory Corporation of America Holdings (LabCorp), Lumiradx Healthcare Private Limited, Merck KGaA, Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SD Biosensor, Inc., Sekisui Diagnostics, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, and Zoetis Inc..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the C-Reactive Protein Testing Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the C-Reactive Protein Testing Market?
  3. What is the competitive strategic window for identifying opportunities in the C-Reactive Protein Testing Market?
  4. What are the latest technology trends and regulatory frameworks in the C-Reactive Protein Testing Market?
  5. What is the market share of the leading vendors in the C-Reactive Protein Testing Market?
  6. Which modes and strategic moves are suitable for entering the C-Reactive Protein Testing Market?


Note: PDF & Excel + Online Access - 1 Year

Table of Contents

188 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. C-Reactive Protein Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need to measure inflammation caused by a wide variety of health conditions
5.1.1.2. Rising incidence of chronic disorders and growing geriatric population
5.1.1.3. Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
5.1.2. Restraints
5.1.2.1. Issues associated with efficacy and specificity of C-Reactive protein testing
5.1.3. Opportunities
5.1.3.1. Technological advancements pertaining to conventional CRP tests
5.1.3.2. Research on C‐reactive protein in gastrointestinal diseases of dogs
5.1.4. Challenges
5.1.4.1. Stringent approval processes for testing techniques and products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. C-Reactive Protein Testing Market, by Assay Type
6.1. Introduction
6.2. Chemiluminescence Immunoassay
6.3.1. Free T3
6.3.2. Free T4
6.3.3. Thyrotropin Levels
6.3. ELISA
6.4.1. Clinical
6.4.2. Nonclinical
6.4. Immunoturbidimetric Assay
6.5. Radioimmunoassay
6.6.1. Autoantibodies Against Thyrotropin Receptor
6.6.2. Human Serum Thyroglobulin Autoantibodies
6.6.3. Thyroperoxidase Autoantibodies
7. C-Reactive Protein Testing Market, by Disease Area
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Diseases
7.4. Endometriosis
7.5. Inflammatory Bowel Disease
7.6. Lupus
7.7. Rheumatoid Arthritis
8. C-Reactive Protein Testing Market, by Detection Range
8.1. Introduction
8.2. cCRP
8.3. Conventional CRP
8.4. hs-CRP
9. C-Reactive Protein Testing Market, by End-User
9.1. Introduction
9.2. Assisted Living Healthcare Facilities
9.3. Clinics
9.4. Hospitals
9.5. Laboratories
10. Americas C-Reactive Protein Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific C-Reactive Protein Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa C-Reactive Protein Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Abcam PLC
14.1.3. Alere Inc.
14.1.4. BIOMÉRIEUX
14.1.5. BODITECH MED, Inc.
14.1.6. CTK Biotech Inc.
14.1.7. Danaher Corporation
14.1.8. DiaSorin S.p.A.
14.1.9. Eurolyser Diagnostica GmbH
14.1.10. F. Hoffmann-La Roche Ltd.
14.1.11. Fujifilm Corporation
14.1.12. Getein Biotech, Inc.
14.1.13. HORIBA, Ltd.
14.1.14. Laboratory Corporation of America Holdings (LabCorp)
14.1.15. Lumiradx Healthcare Private Limited
14.1.16. Merck KGaA
14.1.17. Ortho Clinical Diagnostics
14.1.18. Quest Diagnostics Incorporated
14.1.19. Randox Laboratories Ltd.
14.1.20. SD Biosensor, Inc.
14.1.21. Sekisui Diagnostics
14.1.22. Siemens Healthineers AG
14.1.23. Thermo Fisher Scientific, Inc.
14.1.24. Trinity Biotech PLC
14.1.25. Zoetis Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us